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ABSTRACT 
Aceto-phospholipids were prepared enzymatically by incorporating the acetate group at sn-1 or sn-2 position 
with out acetylating the amine group of phospholipids. There are a sharp change in surface properties after 
acetylation. At the same time the emulsifying properties of aceto-phospholipids is also remarkable than 
original soy phospholipids. We have got the separate droplet size distribution pattern of water in oil type of 
emulsion in presence of different aceto phospholipids compare to original soy phospholipids. The 
emulsification properties of newly prepared aceto-phospholipids were explained from the HLB values. The 
biological activities of the aceto-phospholipid were also highlighted here using some reported articles. 
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Introduction 
Phospholipids have many applications in the 
food industry as natural emulsifier, stabilizer 
and antioxidants1-3 as well as in cosmetic and 
pharmaceutical industry. The emulsifying 
properties of natural phospholipids need 
improvement because the emulsifying activity 
of the phospholipids component compete with 
each other 4. By exchanging the fatty acid 
profiles asymmetrically in the phospholipid 
molecules, new physical properties of 
phospholipid can be achieved. These modified 
phospholipids can be used in liquid/membrane 
research or as new type of emulsifier in for 
food, cosmetic or medicinal substances 5. The 
modification process for phospholipids may be 
split into three categories – those based on 
physical separation, those based on enzymatic 
modifications and those based on chemically 
catalysed modification. 
Acetylated phospholipids exhibit improved 
fluid properties and improved water 
dispersability. Thus the oil-in-water 
emulsifying properties are enhanced and it is 
effective for a wide variety of food 
formulation. Acetylation occurs primarily on 
the amino group of phosphatidylethanolamine. 
There are several chemical processes reported 
to prepare aceto-phospholipid using acetic 
anhydride or acetic acid as acylating agent but 
generally, chemical methods suffer various 
drawbacks such as low yields, and 
decomposition of products that result in dark 
colored reaction products. A more common 
approach has been to carry out lipase-mediated 
transesterification of fully acetylated 
phospholipids with acyl donor such as fatty 
acids or a methyl ester6-9. Acetylation of 
phospholipids by enzymatic esterification 
process was also reported by Prasad et. al .10 by 
overcoming the disadvantage of chemical 
method. 
The aim of our study was to prepare aceto-
phospholipids by the lipase catalyzed trans-
esterification by using methyl acetate, ethyl 
acetate and butyl acetate as acetate donor and 
evaluate the surface-active properties of the 
aceto-phospholipids prepared in sight of its 
application to the health sciences.  
Experimental Procedure 
Materials   
Crude soy phospholipids, used in the research 
work were supplied by Vippy Industries Ltd. 
(M. P. India). The enzyme lipozyme TLIM 
used, as biocatalyst were gift of NOVOZYME 
South Asia Pvt. Ltd, Bangalore, India. All 
others chemicals and reagents used for this 
purpose were purchased from S. D. Fine 
chemicals, India 
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Methods 
Modification of Soy Phospholipids by 
Acetates by Enzymatic Trans-esterification 
Reaction 
To prepare the aceto phospholipids, 
phospholipids and acetates (methyl acetate, 
ethyl acetate and butyl acetate) were taken in 
1:5 by the proportion of weight ratio. The 
enzyme- RMIM was used for trans-
esterification reaction. The reaction was 
continued for 7 days. After complete removal 
of acetates the trans-esterified phospholipid 
was separated from the mixed methyl ester of 
the fatty acids displaced from soya 
phospholipid by several extractions with 
acetone. Acetone soluble portion contained 
methyl esters of these fatty acids displaced 
from soy phospholipids and trace amount of 
acetates. Acetone insoluble portion contained 
the aceto-phospholipids. The final separation 
of aceto-phospholipid was made by preparative 
thin layer chromatography on silica gel layer. 
For 8 days samples were collected at different 
time intervals (at 2nd, 4th 6th day) for the 
kinetics study of trans-esterification reaction. 
Preparation of oil-in-water type of 
emulsion: 
Oil in water (o/w) type of emulsion was 
prepared by mixing different oils in water in 
the ratio 1:4 by stirring at 3000 rpm for one 
hour with different modified phospholipids 
(0.1% of total weight of materials) in different 
amount to stabilize the emulsion and the 
effects were determined. The emulsions were 
allowed to settle at a constant temperature 
without any further shaking. The emulsion 
height was measured after 24h. The 
emulsification index (E24) was calculated by 
determining the percentage volume occupied 
by the emulsion after 24h.   
Determination of Fatty Acid Composition 
by Gas-Liquid Chromatography 
Methyl esters of the component fatty acids of 
phospholipids were prepared by the method of 
Litchfield 11 and analysed by GLC analysis. 
The methyl esters of fatty acids were analyzed 
on a Hewlett-Packard gas chromatograph (HP 
5890A). (Palo Alta CA), equipped with a 
flame ionization detector (FID) by Gas Liquid 
Chromatography. The analysis was done with 
a polar column. The polar column consist of 
chromosorb-WHP coated with DEGS (6 X 
1/8 id ) and the non polar column consist of  
chromosorb – WHP coated with SE30 (2 m 
length, od 1/8”). But the amount of 
incorporation of acetate (-COCH3-) group in 
the phospholipid molecule could not determine 
by GLC analysis. 
Test for amino-acid group in the modified 
phospholipids 
One drop of sample (modified phospholipids) 
is poured on a piece of filter. Then a circle is 
drawn around the spot with a soft pencil and 
allowed the spot to dry thoroughly. The 0.6% 
ninhydrin solution (in acetone) is sprayed on 
the filter paper. After 20 minutes a violet blue 
colour is appeared on the spot of sample.  
Measurement of Saponification value and 
amount of fatty acid collected from product 
Saponification value and amount of fatty acid 
collected from original and different aceto-
phospholipids prepared by enzymatic and 
chemical catalytic trans-esterification reaction 
of phospholipids and different acetates were 
measured by AOCS method. 
Measurement of droplet size of w/o and o/w 
type of emulsion 
The viscosity of emulsion was measured by 
Oswald viscometer (viscometer const. 1.12 and 
0.3094) and the particle size was measured by 
Malvern Zetasizer 1000HS.    
Measurement of Interfacial Tension 
Interfacial tension of solvent (chloroform) as 
well as the chloroform solution of the original 
and the different modified phospholipids 
against water was determined by well-known 
drop weight method 12.  
Results and Discussion 
These modified phospholipids had the 
significant change in surface active properties 
like effectiveness of interfacial tension 
reduction (CMC ), critical micelle concentration 
(CMC), maximum surface excess 
concentration ( max ), minimum area/molecule 
at the interface (min ). The change in fatty acid 
composition of the modified product and 
original phospholipids were given in table-1. 
Finally the presence of acetate group in 
modified product EPE1 was confirmed by 
NMR spectrum (Fig-1).   
Table-1: Fatty acid composition of original and different acetylated phospholipid (by enzyme 
(RM IM) catalysed and chemical catalyzed reaction) 
Sample C16:0 C18:0 C18:1 C18:2 C18:3 
 
PL 
 
27.0 1.9 14.1 52.9 3.3 
BPE1 
 
16.1 2.3 18.9 58.7 3.4 
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EPE1 
 
17.9 2.5 18.3 57.9 3.3 
MPE1 
 
18:1 2.5 18.3 56.9 3.4 
 
 
BPE1 = Phospholipid modified by butyl acetate by RM IM enzyme 
EPE1 = Phospholipid modified by ethyl acetate by RM IM enzyme 
MPE1 = Phospholipid modified by methyl acetate by RM IM enzyme 
Reaction Temperature = 55-600C 
Reaction Time = 7 days 
Reaction Condition = By magnetic stirring at 600 rpm 
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Fig.-1 Proton NMR Spectrum of EPE1 
 
The trans-esterified soy phospholipids 
containing noticeable quantities of the acetate 
group were examined for interfacial tension 
values (table-2) against water at 270C. The 
interfacial tension measurement definitely 
showed that incorporation of acetate into soy 
phospholipids increased the interfacial tension 
against water. The interfacial tension of 
chloroform/water at 270C is 33 mN/m. For the 
presence of original soy phospholipids (0.1% 
solution) this value was reduced to 13.2 mN/m. 
The saponification values of original and 
modified phospholipiuds have also been listed 
in table-2. This value is also higher than 
original phospholipids. Acetate group has been 
incorporated in soy phospholipid by replacing 
the long chain fatty acids from the original soy 
phospholipids. For this there was a change in 
saponification value. Other surface properties 
and thermodynamic properties were listed in 
table-2. These values were calculated form the 
graphical presentation of log of molar 
concentration vs. interfacial tension of original 
and different aceto-phospholipids The CMC 
values depend on the hydrocarbon chain length 
of the surface active molecule. In 
enzymatically modified product EPE1 
hydrocarbon chain length from sn-1 position 
decreased as a result of the acetate group 
consequently the CMC value was decreased. 
The surface excess concentration (max) in 
mol/cm2 and minimum area/molecule (Amin) in 
Å2 were calculated13 Gibbs Adsorption 
Equation. 
Table-2:Surface Properties and thermodynamic properties of different acetylated phospholipid 
 
Sample I. F. 
(Nm/m) 
CMC 
(Nm/m) 
CMC min X 10-10 
(Moles/cm2) 
Amin (Å)2 -G0 mic 
(KJ/mol) 
Sap. 
Value 
(%) 
Fatty 
acid 
collected 
%(w/w) 
PL 13.2 24.2 5.16 X 10-
7 
1.6 87.3 36 
 
197.0 
 
70.2 
EPE1 23.5 21.6 2.86x10-6 1.09 152 31.8 
 
254.0 
 
47.2 
  
CMC       = interfacial tension at critical micellization concentration, 
 min  = surface excess concentration of surface active molecule,  
Amin  = minimum area / molecule, 
CMC  = critical micellization concentration  
G 0mic = standard free energy change of micellization 
I. F. = Interfacial Tension 
Sap. Value = Saponification value 
PL = Soy phospholipids 
EPE1 = Phospholipid enzymatically modified by ethyl acetate 
(All measurements were done at 270C. At 270C the value of chloroform/water interfacial tension 
is 33.5 dynes/cm) 
 
Aceto-phospholipids have a pronounced effect 
on the emulsification process. The behavior of 
oil-in water types of emulsions was studied in 
presence of aceto-phospholipids and original 
phospholipids. We have got the different types 
of droplet distribution of oil-in-water emulsion 
could be seen in presence of original and 
EPE1. Fig-3 shows the droplet distribution 
pattern of sunflower oil-in-water and coconut-
oil-in-water in presence of original 
phospholipids. This distribution pattern was 
very broad. Slightly narrow distribution pattern 
was observed for the enzymatically prepared 
aceto-phospholipids (EPE1) and very narrow 
distribution for chemically prepared aceto-
phospholipids (presented in Fig.-4 and Fig.-5) 
appears that sufficient hydrocarbon chain 
length of emulsifier is necessary to make oil-
in-water-type of emulsion of small size 
distribution. The value of emulsifying index 
(E24) of enzymatically prepared and 
chemically prepared aceto-phospholipid with 
original phospholipid is shown in Fig.-6 which 
reveals stabilization the oil-in-water emulsion. 
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Fig.-4: Droplet size distribution of different type of oil in water 
              emulsion stabilised by soya phospholipids
 Sunflower oil
 Coconut oil
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Fig.-5: Droplet size distribution of different type of oil in water emulsion
               stabilised by acetophospholipids(EPE1)
 coconut oil/water
 sunflower oil/water
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Fig.-7: Emulsifing index (E24) of different oil in water type of emulsion in presence 
              of original and different acetophospholipis EPC1(0.12%) and EPE1(0.24%) 
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Important Application of Phospholipids in 
Health Sciences 
The human body uses phospholipids as 
emulsifiers. Phospholipids are basic substances 
to maintain life activity. They are widely 
distributed in humans, animals, plants, and so 
on. Phospholipids are indispensable 
components of all cellular and sub-cellular 
membranes, they can arrange as bilayer 
membranes due its emulsifying properties. In 
addition to assembling the membrane, 
phospholipids are also used to assemble the 
circulating lipoproteins, the main task of which 
is to transport lipophilic triglycerides and 
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cholesterols through the hydrophilic blood. 
Together with cholesterols and bile acids, they 
form mixed micelles in the gallbladder to 
promote the absorption of fat-soluble 
substances. The human body also uses 
phospholipids as the surface-active wetting 
agents in the pleura and alveoli of lung, 
pericardium, joints, etc. Different kinds of 
phospholipids have some general properties, 
but they also own their unique physiological 
functions (Table 3).  
Table 3:  Physiological Properties of major Phospholipids 
Phosphatidylcholine (PC),  An important substrate of synthesis of the neurotransmitter acetylcholine, 
and having the function of nourishing the brain and improving 
intelligence [ 
Phosphatidylethanolamine 
(PE), 
Playing an important role in membrane fusion 
Phosphatidylserine (PS), a. Improving function of nerve cells, regulating the conduction of nerve 
impulse, and enhancing the memory function of brain [29].  
b. The common feature of apoptosis [30].  
c. The main acidic phospholipids of membranes of platelets, and involved 
in the clotting process  
Cardiolipin (CL) A phospholipid of unusual structure is localized almost exclusively to 
inner mitochondrial membrane, is particularly rich in unsaturated fatty 
acids. This phospholipid plays an important role in mitochondrial 
bioenergetics by affecting the activity of key proteins of mitochondrial 
inner membrane  
Phosphatidylinositol (PI) The precursor of second messenger, which plays a very important role in 
the process of transmission of messages in neural system 
Sphingomyelins (SM) Along with cholesterol, constituting the key components of the stable, 
detergent-resistant nanodomains in membranes, called functional lipid 
rafts which have been identified as the important membrane structure of 
signal transduction, protein transport and sorting of membrane 
components [ 
Drug delivery systems (DDS) is the prime 
system of therapeutics. In a suitable dosage 
and mode of administration to achieve the best 
therapeutic effect is the research objective of 
DDS. As main components of cellular 
membrane, phospholipids have excellent 
biocompatibility and for their amphiphilic 
structures, it is being a good DDS. 
Phospholipids have a propensity to form 
liposomes, which can be employed as the drug 
carriers14. Phospholipids have good 
emulsifying property which can stabilize the 
emulsions. In addition, phospholipids as 
surface-active wetting agents which can coat 
on the surface of crystals to enhance the 
hydrophility of hydrophobic drugs. The above 
properties are successfully employed in the 
DDS design. Phospholipids based DDS have 
been found promising for better and effective 
delivery of drugs and providing much 
appropriate systematic drug delivery. In recent 
years, a variety of phospholipid-related 
formulations, such as Doxil®, Cleviprex®, 
Valium® and Silybin Phytosome™, have been 
used in clinic, and achieving good results. 
Phospholipid takes an important role in the 
development of liposomal drug delivery 
system. Liposomes are vesicles prepared with 
phospholipids as the main substance, the 
structure of which is similar to cellular 
membrane. Liposomes as carriers of 
therapeutic drugs have attracted attention more 
than 40 years. As a DDS, liposomes have 
many advantages as follows: delivering both 
hydrophilic and lipophilic drugs (Fig. 6), 
possessing targeting, controlled release 
properties, cell affinity, tissue compatibility, 
reducing drug toxicity and improving drug 
stability.  
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Fig. 7: Structure of liposome 
During the researches, the conventional 
structures of the liposomes have some changes, 
which have brought out a series of new type 
liposomes, such as long-circulating liposomes, 
stimuli-responsive liposomes, cationic 
liposomes and ligand-targeted liposomes. 
Liposomes can serve as the carriers of 
antitumor drugs, antifungal drugs, analgesic 
drugs, gene therapeutics and vaccines, and 
there have been some liposomal formulations 
industrialized which are listed in Table 4. 
Table 4:  Approved liposomal formulations  
Product Phospholipids Drug Year approved 
Ambisome HSPC and DSPG  Amphotericin B 1990 (Europe) 
Doxil HSPC and DSPE-
PEG2000  
Doxorubicin  1995 1999 2003 
(Europe, Canada) 2007 
DaunoXome DSPC  Daunorubicin  1996 (Europe) 1996 
(USA) 
1997 (USA), 2000 
Myocet™ EPC Doxorubicin  2000 (Europe) 
DepoDur™ DOPC and DPPG  Morphine sulfate 2004 
DepoCyt DOPC and DPPG  Cytosine 1999 
Arabinoside 
1999  
Lipo-Dox DSPC and DSPE-
PEG2000  
Doxorubicin  2001 (Taiwan) 
Marqibo ESM  Vincristine  2012 (USA)  
 
Phospholipids as zwitterionic surfactants can 
be used as emulsifying agent of O/W type 
emulsions, and due to their biological and non-
toxic characteristics, they can be used as 
emulsifiers for intravenous injection. The O/W 
type emulsions are mainly composed of two 
parts: the oil core and the emulsifying agents 
on the surface. Unlike liposomes, fat 
emulsions are suitable for large-scale industrial 
production and relatively stable below 25 C for 
long term. More importantly, a large quantity 
of lipophilic drugs can be dissolved in the 
hydrophobic core of emulsions [15]. 
 
Table 6:  Representative list of currently marketed drug containing injectable emulsions 
Product Drug Market Emusifier 
Cleviprex® Clevidipine Butyrate USA EP 
Diazemuls® Diazepam Europe, Canada, 
Australia 
EP 
Diazepam-Lipuro®  
Diazepam 
 
Europe, Canada, 
Australia 
EL 
Diprivan® Propofol Worldwide EL 
Etomidat-Lipuro® Etomidate Germany EL 
Fluosol-DA® Perfluorodecalin Worldwide EP and pluronic F68 
Perflurotripropylamine 
Liple® 
Alprostadil (PGE1) Japan EP 
Limethason® Dexamethasone 
Palmitate 
Japan, Germany EL 
Lipo-NSAID® Flurbiprofen axetil Japan EL 
Stesolid® Diazepam Europe EP 
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Vitalipid® Vitamins A, D2, E, K1 Europe EL 
EL: egg lecithin EP: egg phospholipid. 
 
Conclusion 
Aceto soy phospholipids were prepared by 
incorporating the acetate group by enzymatic 
trans-esterification using methyl acetate. Our 
study showed that the newly prepared aceto 
phospholipids act as better emulsifiers in the 
oil-in-water emulsion than original soy 
phospholipids. The surface active and 
thermodynamic properties of the aceto-soy 
phospholipids are different from those of the 
original soy phospholipids. As different 
phospholipids take a major role in a drug 
delivery system, our modified aceto-
phospholipid being a good emulsifying and 
surface active properties can take a new role in 
DDS. Our future work is on searching the role 
of aceto-phospholipid in Drug Delivery 
System.  
 
Acknowledgement 
 
Dr. S. Das is thankful to DDE, Vidyasagar 
University for giving working opportunity.  
 
Reference 
 
1. B. Szuhal,  American oil Chemist Society 
Press, Champaign, IL (USA), 1998 
2. Nieuwenhuyzen W. Van; B,. Szuhaj, Fett.  
Effects of lecithins and proteins on the 
stability of emulsions. European Journal of 
lipid science and technology 1998, 100, 
282-291 
3. W. Van Nieuwenhuyzen, The Industrial 
uses of Special Lecithins: A ReviewJ. Am. 
Oil Chem. Soc.  1981, 58, 886-888 
4. Marion G. Priebe and Jolene R. 
McMonagle. Effects of Ready-to-Eat-
Cereals on Key Nutritional and Health 
Outcomes: A Systematic Review. 2016; 
11(10): e0164931 
5. I. Svensson; Patrick Adlercreutz; Bo 
Mattiasson, Lipase- catalyzed 
transesterification of phosphatidylcholine 
at controlled water activity J. Am. Oil 
Chem Soc. 1992, 69, 10, 986-991 
6. Adlercreutz, P.; H. Budde; E. wehtje; An 
enzymatic method for the synthesis of 
mixed-acid phosphatidylcholine 
Biotechnol. Bioeng. 2002, 78, 403-411  
7. Ghosh M, Bhattacharyya DK  Soya 
lecithin-monoester interchange reaction by 
microbial lipase. J. Am. Oil Chem.  Soc. 
1997; 74: 761–763. 
8. Haraldsson, G.G.; A. Thorarenson; 
Optimization of Hydrolysis in Organic 
Solvents J. am. Oil Chem Soc. 1999, 76, 
1143-1149 
9. Mustranta, A.; T. Suortti, K. Poutanen; 
Transesterification of Phospholipids in 
Different Reaction Conditions, J. Am. Oil 
Chem Soc. 1994, 71, 1415-1419 
10. R. B. N. Prasad: U.S. P`at 63.6003 
11.  Litchfield,C. – Analysis of triglycerides, 
Academic Press, New York, 1972, p17-35, 
12. Harkins, D. and F. E. Brown J. A. C. S. 
Determination of Surface Ten- sion (Free 
Surface ... Height Method.1919, XLI, 499-
524,  
13. Yun-Peng, Milton J. Rosen, Philip K. 
Vinson and Stephen W. Morrall J. 
Surfactant and. Detergent. 1999;2(3): 357-
362 
14. a) Pt Cullis, De Kruijff B. Biochim Biophys 
Acta (BBA) 1979;559(4):399e420 and 
Reviews on Biomembranes. b) Yang R, 
Zhang X, Li F, et al. Colloid Surf A 
Physicochem Eng Asp 
2013;436(0):434e442; c) Haynes DH. 
Google Patents. 1992; d) Allen TM, Cullis 
PR. Adv Drug Deliv Rev 
2013;65(1):36e48; e) Hippalgaonkar K, 
Majumdar S, Kansara V. AAPS 
PharmSciTech 2010;11(4):1526e1540; f) 
Rupp C, Steckel H, Mu¨ ller BW. Int J 
Pharm 2010;395(1):272e280; g) 
Bhattacharya S. Int J Health Res 
2009;2(3):225e232. 
15. Hansrani P, Davis S, Groves M. PDA J 
Pharm Sci Tech JulyeAugust 
1983;37(4):145e150. PDA J Pharm Sci 
Technol 1983;37: 145e150. 
 
 
 
Conflict of Interest: None  
Source of Support: Nil 
 
